×

Pfizer and Astrazeneca: Round 2?

1:45 AM ET Tue, 26 Aug 2014

CNBC's Catherine Boyle reports on whether Pfizer might make another bid for Astrazeneca three months after the collapse of its £69.4 billion ($115.14 billion) approach.